مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

38
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

16
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Potential Use of Umbilical Cord Mesenchymal Stem Cells for Improving Patients with COVID-19: A Review

Pages

  0-0

Abstract

 The SARS-CoV-2 virus is a member of the coronavirus family that caused the COVID-19 respiratory disease epidemic in China before the global pandemic of the disease in late 2019. The virus's genome is of 79% similarity to that of the SARS-CoV virus, using the ACE2 receptor to enter its target cells. The most common symptoms of this disease include fever, cough, pulmonary involvement, and sometimes gastrointestinal symptoms. A decline in both the number and function of lymphocytes and a severe increase in leukocyte inflammatory activity are among the most obvious immunological complications of this disease. If the immune system response to the virus is inadequate, the disease can become acute. Immune cells activity leads to a sharp increase in the number of blood cytokines, causing "cytokine storm, " which in turn can cause systematic damages to the heart, lungs, and kidneys, and ultimately may lead to death. Mesenchymal Stem Cell therapy offers a promising approach to reducing the destructive impacts of infection in patients with COVID-19. Mesenchymal Stem Cells can secrete immune-modulating factors that suppress cytokine storms. Furthermore, the role of Mesenchymal Stem Cells in preventing cell death and inhibiting tissue fibrosis has been well demonstrated. This review shows available Clinical Trials that have tapped into the therapeutic potential of the Umbilical Cord Mesenchymal Stem Cells in patients with COVID-19.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    Motallebzadeh Khanmiri, Jamal, Khani Eshratabadi, Mohammad, Nasirzadeh, Amirreza, Nematzade, Mahdie, Talebpour, Amir, & MOUSAVI, SEYED HADI. (2021). Potential Use of Umbilical Cord Mesenchymal Stem Cells for Improving Patients with COVID-19: A Review. ARCHIVES OF MEDICAL LABORATORY SCIENCES, 7(1), 0-0. SID. https://sid.ir/paper/1020182/en

    Vancouver: Copy

    Motallebzadeh Khanmiri Jamal, Khani Eshratabadi Mohammad, Nasirzadeh Amirreza, Nematzade Mahdie, Talebpour Amir, MOUSAVI SEYED HADI. Potential Use of Umbilical Cord Mesenchymal Stem Cells for Improving Patients with COVID-19: A Review. ARCHIVES OF MEDICAL LABORATORY SCIENCES[Internet]. 2021;7(1):0-0. Available from: https://sid.ir/paper/1020182/en

    IEEE: Copy

    Jamal Motallebzadeh Khanmiri, Mohammad Khani Eshratabadi, Amirreza Nasirzadeh, Mahdie Nematzade, Amir Talebpour, and SEYED HADI MOUSAVI, “Potential Use of Umbilical Cord Mesenchymal Stem Cells for Improving Patients with COVID-19: A Review,” ARCHIVES OF MEDICAL LABORATORY SCIENCES, vol. 7, no. 1, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/1020182/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button